News

The FDA Takes a Trial-Lawyer Turn
Commissioner Makary touts dubious evidence on talcum powder at a rushed hearing.
FDA requires Covid vaccine makers to expand warning about risk of rare heart inflammation
The US Food and Drug Administration will now require Covid-19 vaccines from Pfizer/BioNTech and Moderna to use expanded ...
FDA won’t approve COVID shot for healthy, non-elderly population
The Food and Drug Administration will no longer approve COVID-19 vaccines for healthy people under 65 without rigorous trials ...
Did Johnson & Johnson put profit over safety? | The Excerpt
For generations of Americans the Johnson & Johnson brand has been a beloved one, as quintessentially American as baseball and ...
J&J Says FDA Advisory Panel Favors Benefit-Risk Profile of Darzalex Faspro in Myeloma Treatment
The pharmaceutical company said Tuesday the FDA's Oncologic Drugs Advisory Committee voted 6-2 in favor of Darzalex Faspro, or daratumumab and hyaluronidase-fihj, to treat adult patients with ...
FDA panel is split on updates to COVID shots as questions loom for fall vaccinations
Government vaccine advisers are meeting to decide if the recipe for COVID-19 vaccines needs updating for this fall and winter ...
Medscape15h
FDA Advisory: Daratumumab Wins for Smoldering Myeloma Glofitamab Loses for Early Line R/R Diffuse Large B-Cell Lymphoma
The FDA is likely to approve the first treatment for smoldering multiple myeloma but pass on a new option relapsed/refractory DLBCL, after votes by its Oncologic Drugs Advisory Committee.
FDA Changes May Limit COVID Vaccine Access—Drawing Some Criticism. Here’s What We Know
The change marks a shift in the Food and Drug Administration’s policy on approving COVID-19 vaccines, which the new ...
WTVR.com5h
FDA advisory committee meets on COVID-19 vaccine after putting new restrictions on approvals
The vaccine advisory committee for the Food and Drug Administration met Thursday to discuss potential changes to the formula for COVID-19 vaccines for 2025-2026.